↓ Skip to main content

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Published in
Frontiers in oncology, May 2021
DOI 10.3389/fonc.2021.664421
Pubmed ID
Authors

Ying Zhang, Jiaqi Li, Xiaoyan Lou, Xiaochen Chen, Zhou Yu, Liqing Kang, Jia Chen, Jin Zhou, Xiangping Zong, Zhen Yang, Minghao Li, Nan Xu, Sixun Jia, Hongzhi Geng, Guanghua Chen, Haiping Dai, Xiaowen Tang, Lei Yu, Depei Wu, Caixia Li

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 14%
Unspecified 2 9%
Researcher 2 9%
Student > Ph. D. Student 2 9%
Other 1 5%
Other 2 9%
Unknown 10 45%
Readers by discipline Count As %
Medicine and Dentistry 3 14%
Unspecified 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Agricultural and Biological Sciences 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 2 9%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2021.
All research outputs
#15,751,285
of 25,387,668 outputs
Outputs from Frontiers in oncology
#4,974
of 22,433 outputs
Outputs of similar age
#238,776
of 459,432 outputs
Outputs of similar age from Frontiers in oncology
#272
of 1,388 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,432 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,388 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.